Fortress Biotech Inc. Overview
Fortress Biotech, Inc., a prominent player in the biopharmaceutical sector, continues to focus on acquiring, developing, and commercializing innovative pharmaceutical and biotechnology products. As a company listed on the Nasdaq stock exchange, it operates within the broader Health Care sector, specifically under the Biotechnology industry. With a market capitalization of approximately $72,006,497 USD, Fortress Biotech remains a significant entity in its field.
Recent Financial Performance
As of August 27, 2025, Fortress Biotech’s stock closed at $2.42. This price reflects a fluctuation within the year, with a 52-week high of $2.51 recorded on the same day and a 52-week low of $1.33 on April 8, 2025. These figures highlight the company’s performance dynamics over the past year, indicating periods of both growth and decline.
Strategic Focus and Operations
Fortress Biotech is dedicated to providing funding and management services to its portfolio companies, known as Fortress Companies. The company actively seeks various forms of support, including licensing agreements, partnerships, joint ventures, and both public and private financing, to bolster its research and development initiatives. This strategic approach aims to enhance the development and commercialization of novel pharmaceutical and biotechnology products.
Further Information
For more detailed insights into Fortress Biotech’s activities and strategic initiatives, stakeholders and interested parties are encouraged to visit their official website at www.fortressbiotech.com . The website offers comprehensive information about the company’s ongoing projects, partnerships, and future plans within the biopharmaceutical landscape.